Muller & Phipps (India) Limited (BOM:501477)
India
· Delayed Price · Currency is INR 233.00
0.00 (0.00%)
At close: Apr 24, 2026
Muller & Phipps (India) Revenue
Muller & Phipps (India) had revenue of 14.54M INR in the quarter ending December 31, 2025, a decrease of -9.22%. This brings the company's revenue in the last twelve months to 70.90M, up 33.52% year-over-year. In the fiscal year ending March 31, 2025, Muller & Phipps (India) had annual revenue of 61.94M with 39.83% growth.
Revenue (ttm)
70.90M
Revenue Growth
+33.52%
P/S Ratio
2.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
145.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 61.94M | 17.65M | 39.83% |
| Mar 31, 2024 | 44.30M | 2.62M | 6.29% |
| Mar 31, 2023 | 41.68M | 2.38M | 6.04% |
| Mar 31, 2022 | 39.30M | -2.96M | -7.01% |
| Mar 31, 2021 | 42.27M | 4.85M | 12.96% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zenlabs Ethica | 493.24M |
| Pentokey Organy (India) | 45.60M |
| Evoq Remedies | 407.29M |
| Dipna Pharmachem | 1.07B |
| Medico Intercontinental | 845.68M |
| Chandra Bhagat Pharma | 493.95M |
| Checkpoint Trends | 2.95B |
| Priya | -194.00K |